Question 4. What are the strategies for diagnosis and treatment of disorders of glucose metabolism in cystic fibrosis? Diabetes in cystic fibrosis: Pathophysiology and diagnostic criteria of disorders of glucose metabolism;Question 4. Quelles stratégies diagnostiques et thé rapeutiques des troubles du métabolisme glucidique au cours de la mucoviscidose? Diabète de la mucoviscidose: Physiopathologie et critères diagnostiques des troubles du métabolisme glucidique

Archives de Pediatrie

Volumn 10, Issue SUPPL. 3, 2003, Pages

  Mosnier Pudar, H ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

Cystic fibrosis; Diabetes

Indexed keywords

CLINICAL FEATURE; CONFERENCE PAPER; CYSTIC FIBROSIS; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; INSULIN CLEARANCE; INSULIN SENSITIVITY; PATHOPHYSIOLOGY;

EID: 0141459205     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(03)90630-0     Document Type: Conference Paper

References (39)

1. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 1994; 83: 849-53.
2. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of diabetes mellitus on clinical status in patients with cystric fibrosis. Eur J Pediatr 1992; 151: 684-7.
3. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97.
4. Soejima K, Landing BH. Pancreatic islets in older patients with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr Pathol 1986; 6: 25-46.
5. Robert JJ, Grasset E, de Montalembert M, Chevenne D, Deschamps I, Boitard C, et al. Recherche de facteurs d'intolérance au glucose dans la mucoviscidose. Arch Fr Pediatr 1992; 49: 17-22.
6. Lanng S, Thorsteinsson B, Pociot F, Marshall MO, Madsen HO, Schwartz M, et al. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr 1993; 82: 150-4.
7. Trezise AEO, Buchwald M. In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature 1991; 353: 434-7.
8. Dodge JA, Morrison G. Diabetes mellitus in cystic fibrosis: a review. J R Soc Med 1992; 85 Suppl 19: 25-8.
9. Krueger LJ, Lerner A, Katz SM, Mack R, Holsclaw DS, Lebenthal E. Cystic fibrosis and diabetes mellitus: interactive or idiopathique? J Pediatr Gastroenterol Nutr 1991; 13: 313-24.
10. Couce M, O'Brien TD, Moran A, Roche PC, Butler PC. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab 1996; 81: 1267-72.
11. Lanng S, Thorsteinsson B, Roder M, Orskov C, Holst JJ, Nerup J, et al. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired and diabetic glucose tolerance. Acta Endocrinol 1993; 128: 207-17.
12. Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF, Hodson ME. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction. Diabet Med 2002; 19: 221-6.
13. Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991; 118: 715-23.
14. Meacham LR, Caplan DB, McKean LP, Buchanan CN, Parks JS, Culler FL. Preservation of somatostatin secretion in cystic fibrosis patients with diabetes. Arch Dis Child 1993; 68: 123-5.
15. Moran A, Pyzdrowski K, Weinber MD, Kahn BB, Smith SA, Adams KL, et al. Insulin sensitivity in cystic fibrosis. Diabetes 1994; 43: 1020-6.
16. Lanng S, Thorsteinsson B, Roder M, Nerup J, Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol 1994; 41: 217-23.
17. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and diabetes late complications. Acta Paediatr 1994; 83: 72-7.
18. Rosenecker J, Eichler I, Kuhn L, Harms HK, von der Hardt J. Genetic determination of diabetes mellitus in patients with cystic fibrosis. J Pediatr 1995; 127: 441-3.
19. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C. Glucose tolerance in patients with cystic fibrosis: a five year prospective study. Br Med J 1995; 311: 655-8.
20. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC, et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988; 112: 373-7.
21. Koch C, Cuppens H, Rainisio M, Madessani U, Harms H, Hodson M, et al. Investigators of the ERCF. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 2001; 31: 1-12.
22. Cucinotta D, De Luca F, Scoglio R, Lombardo F, Sferlazzas C, Di Benedetto A, et al. Factors affecting diabetes mellitus onset in cystic fibrosis: evidence from a 10-year follow-up study. Acta Paediatr 1999; 88: 389-93.
23. Cotellessa M, Minicucci L, Diana MC, Prigione F, Di Febbraro L, Gagliardini R, et al. Phenotype/genotype correlation and cystic fibrosis related diabetes (Italian Multicenter Study). J Pediatr Endocrinol Metab 2000; 13: 1087-93.
24. Rodman HM, Doershuk CF, Roland JM. The interaction of 2 diseases: diabetes mellitus and cystic fibrosis. Medicine 1986; 65: 389-97.
25. Sullivan MM, Denning CR. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics 1989; 84: 642-7.
26. Dodge JA, Morrison G. Diabetes mellitus in cystic fibrosis: a review. J R Soc Med 1992; 85 Suppl 19: 25-8.
27. Stutchfield P, O'Halloran SM, Teale JD, Isherwood D, Smith CS, Heaf D. Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child 1987; 62: 805-10.
28. De Schepper J, Dab I, Derde MP, Loeb H. Oral glucose tolerance testing in cystic fibrosis: correlation with clinical parameters and glycosylated haemoglobin determinations. Pediatrics 1991; 23: 495-8.
29. De Luca F, Arrigo T, Di Benedetto A, Tedeschi A, Sferlazzas C, Crisafulli G, et al. Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. Horm Res 1995; 44: 45-50.
30. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999; 45: 61-73.
31. Garagorri JM, Rodriguez G, Ros L, Sanchez A. Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors. J Pediatr Endocrinol Metab 2001; 14: 53-60.
32. Lanng S. Glucose intolerance in cystic fibrosis patients. Paediatr Resp Rev 2001; 2: 253-9.
33. Robert JJ, Mosnier-Pudar H. Diagnosis and treatment of diabetes in adult patients with cystic fibrosis. Rev Mal Resp 2000; 17: 798-801.
34. Cystic Fibrosis Foundation National Patient Registry. 1998. 1997 Annual Data Report. Bethesda, MD.
35. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Resp Crit Care Med 2000; 162: 891-5.
36. Koch C, Rainisio M, Madessani U, Harms UK, Hodson ME, Mastella G, et al. Investigators of the European Epidemiologic Registry of Cystic Fibrosis. Presence of cystic fibrosis -related diabetes is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001; 32: 343-50.
37. Hardin D, LeBlanc A, Lukenbaugh S, Para L, Seilheimer DK. Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics 1998; 101: 433-7.
38. Sullivan MM, Denning CR. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics 1989; 84: 642-7.
39. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994; 83: 72-7.